Clinical Trials Matching Software Market Research Report by Deployment, End-use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

The Global Clinical Trials Matching Software Market size was estimated at USD 172.12 million in 2021 and expected to reach USD 194.27 million in 2022, and is projected to grow at a CAGR 13.12% to reach USD 360.72 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Clinical Trials Matching Software to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Deployment, the market was studied across Cloud & Web Based and On-Premise.

Based on End-use, the market was studied across CROs, Medical Device Firms, and Pharmaceuticals & Biotechnology Companies.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Trials Matching Software market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trials Matching Software Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trials Matching Software Market, including Advarra, Antidote Technologies, Inc., Aris Global, Bsi Business Systems Integration Ag, Clario, Clinical Trials Mobile Application, Evidation Health, Inc., HealthMatch Pty Ltd, Inspirata, Inc., International Business Machines Corporation, IQVIA, Microsoft Corporation, Ofni Systems, PatientsLikeMe LLC, SSS International Clinical Research, Teckro, Tempus Labs, Trialbee AB, TrialSpark, Inc., and Xperii Corporation.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Clinical Trials Matching Software Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trials Matching Software Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trials Matching Software Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Trials Matching Software Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Trials Matching Software Market?
6. What is the market share of the leading vendors in the Global Clinical Trials Matching Software Market?
7. What modes and strategic moves are considered suitable for entering the Global Clinical Trials Matching Software Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising need for clinical trials in healthcare domain
5.1.1.2. Significant requirement for precision oncology
5.1.1.3. Potential demand for virtual trials and automation in the healthcare sector
5.1.2. Restraints
5.1.2.1. Concern associated with accuracy of clinical trial results
5.1.3. Opportunities
5.1.3.1. Ongoing research and development activities in pharmaceuticals and biotechnology scetor
5.1.3.2. Integration of artificial intelligence in clinical trial matching services
5.1.4. Challenges
5.1.4.1. Dearth of skilled and experienced professionals
5.2. Cumulative Impact of COVID-19

6. Clinical Trials Matching Software Market, by Deployment
6.1. Introduction
6.2. Cloud & Web Based
6.3. On-Premise

7. Clinical Trials Matching Software Market, by End-use
7.1. Introduction
7.2. CROs
7.3. Medical Device Firms
7.4. Pharmaceuticals & Biotechnology Companies

8. Americas Clinical Trials Matching Software Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Clinical Trials Matching Software Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Clinical Trials Matching Software Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Advarra
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Antidote Technologies, Inc.
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Aris Global
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Bsi Business Systems Integration Ag
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Clario
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Clinical Trials Mobile Application
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Evidation Health, Inc.
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. HealthMatch Pty Ltd
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Inspirata, Inc.
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. International Business Machines Corporation
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. IQVIA
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Microsoft Corporation
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Ofni Systems
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. PatientsLikeMe LLC
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. SSS International Clinical Research
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Teckro
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Tempus Labs
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Trialbee AB
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. TrialSpark, Inc.
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Xperii Corporation
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing